SPGI vs SRTAW · P/E 27, rev $15.34B vs rev $248.7M
S&P Global Inc (SPGI) versus Strata Critical Medical, Inc. (SRTAW) — a side-by-side from cached financials, not a winner call.
S&P Global Inc (SPGI) is a financial data & stock exchanges company listed on NYSE.
Strata Critical Medical, Inc. (SRTAW) common stock listed on NASDAQ.
Latest reported SPGI revenue for 2025-12-31 was $15.34B. Net income was $4.47B. Revenue was up 7.9% from 2024-12-31 to 2025-12-31. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
Latest reported SRTAW revenue for 2024-12-31 was $248.7M. Net income was -$27.3M. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. SRTAW currently screens at market cap $0.
SPGI currently screens at market cap $127.50B and trailing P/E 27.2. SRTAW currently screens at market cap $0.
Not investment advice. Open the SPGI and SRTAW stock pages for the full models.
Not investment advice.